CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System by Drummond, Rebecca A. et al.
RESEARCH ARTICLE
CARD9-Dependent Neutrophil Recruitment
Protects against Fungal Invasion of the
Central Nervous System
Rebecca A. Drummond1☯, Amanda L. Collar1☯, Muthulekha Swamydas1, Carlos
A. Rodriguez2, Jean K. Lim2, Laura M. Mendez3, Danielle L. Fink3, Amy P. Hsu4, Bing Zhai5,
Hatice Karauzum6, Constantinos M. Mikelis7, Stacey R. Rose1, Elise M. N. Ferre1,
Lynne Yockey1, Kimberly Lemberg8, Hye Sun Kuehn8, Sergio D. Rosenzweig8, Xin Lin9,
Prashant Chittiboina10, Sandip K. Datta6, Thomas H. Belhorn11, Eric T. Weimer12, Michelle
L. Hernandez13, Tobias M. Hohl5, Douglas B. Kuhns3, Michail S. Lionakis1*
1 Fungal Pathogenesis Unit, Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy
and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, United States of
America, 2 Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York,
United States of America, 3 Neutrophil Monitoring Laboratory, Applied/Developmental Research Directorate,
Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland,
United States of America, 4 Immunopathogenesis Section, LCID, NIAID, NIH, Bethesda, Maryland, United
States of America, 5 Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer
Center, New York, New York, United States of America, 6 Bacterial Pathogenesis Unit, LCID, NIAID, NIH,
Bethesda, Maryland, United States of America, 7 Department of Biomedical Sciences, School of Pharmacy,
Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America, 8 Department of
Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, Maryland, United States of America, 9 Department
of Molecular and Cellular Oncology, Division of Basic Science Research, The University of Texas MD
Anderson Cancer Center, Houston, Texas, United States of America, 10 Surgical Neurology Branch,
National Institute of Neurological Disorders and Stroke (NINDS), NIH, Bethesda, Maryland, United States of
America, 11 Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North
Carolina, United States of America, 12 Department of Pathology and Laboratory Medicine, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, 13 Center for
Environmental Medicine, Asthma, and Lung Biology, University of North Carolina at Chapel Hill, Chapel Hill,
North Carolina, United States of America
☯ These authors contributed equally to this work.
* lionakism@mail.nih.gov
Abstract
Candida is the most common human fungal pathogen and causes systemic infections that
require neutrophils for effective host defense. Humans deficient in the C-type lectin pathway
adaptor protein CARD9 develop spontaneous fungal disease that targets the central ner-
vous system (CNS). However, how CARD9 promotes protective antifungal immunity in the
CNS remains unclear. Here, we show that a patient with CARD9 deficiency had impaired
neutrophil accumulation and induction of neutrophil-recruiting CXC chemokines in the cere-
brospinal fluid despite uncontrolled CNS Candida infection. We phenocopied the human
susceptibility in Card9-/- mice, which develop uncontrolled brain candidiasis with diminished
neutrophil accumulation. The induction of neutrophil-recruiting CXC chemokines is signifi-
cantly impaired in infected Card9-/- brains, from both myeloid and resident glial cellular
sources, whereas cell-intrinsic neutrophil chemotaxis is Card9-independent. Taken
together, our data highlight the critical role of CARD9-dependent neutrophil trafficking into
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the CNS and provide novel insight into the CNS fungal susceptibility of CARD9-deficient
humans.
Author Summary
CARD9 is a molecule expressed by mammalian immune cells and is centrally positioned
downstream of several C-type lectin receptors, which sense fungi. The critical role of
CARD9 in the activation of antifungal host defense has been highlighted by the demon-
stration that human mutations that disrupt the function of CARD9 are associated with the
development of spontaneous life-threatening fungal infections, many of which target the
central nervous system (CNS). However, why CARD9-deficient patients develop fungal
disease in the CNS remained unclear. Here, we show that CARD9 is required for the
recruitment of neutrophils, an immune cell critical for antifungal host defense, to the fun-
gal-infected CNS in both mice and humans. Furthermore, we show that CARD9-deficient
mice and humans are unable to produce the molecules (chemoattractants) needed to
recruit neutrophils to the site of infection, thus identifying the mechanism for the striking
absence of these cells in the infected CNS. Our work helps explain why CARD9 deficiency
associates with CNS fungal disease, and furthers our understanding of how antifungal
immunity operates in this complex tissue.
Introduction
Human systemic fungal infections are typically opportunistic and primarily affect patients with
acquired immunodeficiency (i.e. commonly due to HIV infection or modern medical interven-
tions such as cancer chemotherapy and transplantation) or inborn errors of immunity [1, 2].
Systemic candidiasis, in particular, is the most common deep-seated fungal infection in the
developed world and is now the most common cause of nosocomial bloodstream infection in
the US [3]. Despite the availability of potent antifungal drugs, clinical outcomes of infected
patients are often poor leading to significant morbidity and unacceptably high mortality rates
[1]. Adjunctive immune-based therapies are therefore becoming increasingly desirable, yet
their development and success depends on improving our understanding of the cellular and
molecular basis of human antifungal immunity.
Fungi are recognized by the host immune system via innate pattern recognition receptors
(PRRs) that are predominantly expressed by myeloid cells, including neutrophils, monocytes/
macrophages and dendritic cells. C-type lectin receptors (CLRs) are a large class of PRRs of
which several members including Dectin-1, Dectin-2 and Mincle have been shown to play cru-
cial roles in antifungal immunity [4]. These receptors bind components of the fungal cell wall
and this innate recognition event leads to the initiation of intracellular signaling cascades that
stimulate cellular responses such as phagocytosis, induction of the respiratory burst, and pro-
duction of pro-inflammatory chemokines/cytokines [4]. Although different CLRs exhibit inde-
pendent functions, they utilize a common signaling pathway involving the kinase Syk and the
signaling adaptor, CARD9 [5].
CARD9 is one of the most crucial mammalian antifungal immune molecules identified to
date. Genetic deletion of Card9 in mice results in defective pro-inflammatory cytokine produc-
tion by myeloid cells and leads to a substantial increase in mortality following C. albicans chal-
lenge compared to WT mice [6]. CARD9 is also indispensable for antifungal defense in
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humans. Autosomal recessive CARD9 deficiency due to biallelic missense or nonsense CARD9
mutations leads to profound defects in production of pro-inflammatory cytokines in response
to fungal-specific stimuli, including GM-CSF, IL-1β, IL-6 and TNFα [7–14]. Other known
CARD9-dependent functions in humans include CR3-dependent killing of unopsonized yeast
by neutrophils [7, 14, 15], generation of neutrophilic myeloid-derived suppressor cells [16],
and, in some patients, generation of Th17 cells [8, 11].
Along with loss of these CARD9-dependent functions, patients deficient in CARD9 are
highly susceptible to spontaneous development of systemic fungal infections, predominantly
caused by Candida species [7, 8], as well as severe cutaneous and subcutaneous infections
caused by dermatophytes collectively known as deep dermatophytosis [13, 17]. Interestingly, a
large proportion of CARD9-deficient patients develop systemic candidiasis that specifically tar-
gets the central nervous system (CNS) without persistent fungemia [7–9, 12, 18]. In patients
with intact CARD9 signaling, systemic candidiasis is most often associated with the kidney,
liver and spleen [19]. Therefore, this striking CNS-targeted manifestation of systemic candidia-
sis in CARD9-deficient patients suggests that CARD9 is uniquely required for protecting the
CNS from fungal invasion. However, the CARD9-dependent immune effector functions oper-
ating in the CNS remain undefined.
Here, we describe a novel CARD9missense mutation (c.170G>A; p.R57H) identified in an
11 year-old girl with Candidameningoencephalitis. We extensively characterized the impact of
this mutation on the antifungal host response in human myeloid cells, focusing on neutrophils,
which are the primary immune effector cells against systemic C. albicans infections. Further-
more, we phenocopied the human CNS susceptibility to C. albicans infection in Card9 knock-
out (KO) mice, and characterized the Card9-dependent immune protective functions in this
tissue in vivo. We have found that CARD9 is critical for control of fungal invasion in the CNS,
acting to promote fungal-specific and tissue-specific neutrophil trafficking from the blood to
the target organ via neutrophil-targeted chemokine production in both mice and humans.
Results
Candida Spinal Osteomyelitis and Meningoencephalitis in a Patient with
a Novel Homozygous CARD9Missense Mutation
An 11-year-old girl living in North Carolina in the US and born to consanguineous El Salva-
dorian parents presented at 8 years of age with fever, back pain, headache and vomiting and
was diagnosed with T12-L1 spine osteomyelitis with associated diskitis and paraspinal abscess.
She had recurrent oral thrush since birth but no other infections or medical conditions. Verte-
bral body bone biopsy showed granulomatous inflammation and necrosis with abundant Can-
dida pseudohyphae (Fig 1A) and culture of the biopsy sample grew pan-sensitive Candida
albicans. The patient received a 6-month course of fluconazole with clinical improvement.
Approximately 15 months after discontinuation of fluconazole treatment, at the age of 9, the
patient’s infection recurred and she presented with fever, neck and back pain, headache and
vomiting. Cerebrospinal fluid (CSF) analysis, which was performed this time, revealed pleocy-
tosis (213 nucleated cells/μl; 51% lymphocytes, 27% monocytes, 22% eosinophils), elevated
protein (168 mg/dL) and decreased glucose (<20 mg/dL); CSF culture grew pan-sensitive
C. albicans and beta-D-glucan (BDG) in the serum and CSF was markedly elevated at>500.
Magnetic resonance imaging revealed cervical spine osteomyelitis, leptomeningeal enhance-
ment (Fig 1B, black arrows) complicated by a large syrinx (Fig 1B, white arrow) and obstructive
hydrocephalus that necessitated placement of a ventriculoperitoneal shunt, and brain abscesses
(Fig 1C, arrow). No liver, splenic, intestinal or renal lesions were noted on abdominal imaging
and no heart valve vegetation was seen by echocardiogram. Immunologic analyses of
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peripheral blood revealed normal monocyte, neutrophil, eosinophil, CD4+ T, CD8+ T, CD19+
B, and natural killer lymphocyte numbers. Phagocyte oxidative burst assessed by the dihydror-
hodamine (DHR) assay was normal. T-lymphocyte proliferations were normal in response to
PHA and PWM but decreased or absent in response to Candida and tetanus antigens. The lev-
els of the patient’s IgA, IgE, IgG and IgM were normal. Neither her parents nor her siblings
had a history of infections.
Since autosomal recessive CARD9 deficiency has been shown to predispose to Candida
meningoencephalitis [7–9, 12], we sequenced CARD9 exons (S1 Table) and found a homozy-
gous CARD9missense mutation, c.170G>A in exon 3 causing a substitution of histidine for
arginine at position 57 (R57H), a highly conserved residue within the CARD domain of the
CARD9 protein (Fig 1D and S1 Fig). The patient’s parents and brother are healthy and hetero-
zygous for the mutation (WT/c.170G>A) whereas the patient’s healthy sister has WT CARD9
alleles (Fig 1D and 1E), consistent with autosomal recessive CARD9 deficiency with complete
clinical penetrance. The c.170G>Amutation was not found in the 1000 Genomes or ExAC
databases covering 117,000 chromosomes in the specific CARD9 exon, thus this mutation is
unlikely to be an irrelevant polymorphism. In addition, it was predicted to be deleterious by
SIFT (deleterious), CADD [PHRED score 17.7] [20] and PolyPhen 2 [highest possible score of
1] [21]. Collectively, these data strongly suggest that the patient is homozygous for a rare and
deleterious mutant CARD9 allele.
The c.170G>A CARD9Mutation Results in Generation of Full-Length
CARD9 Protein with Impaired Function
Various CARD9mutations that lead to production of full-length, truncated or absent CARD9
proteins have been reported to date [7, 8, 12, 13]. Hence, we next investigated the impact of the
c.170G>Amutation on CARD9 protein levels by FACS and Western blot analyses on the
patient neutrophils and CD14+ monocytes and compared them to that of healthy donor mye-
loid cells. FACS revealed similar expression of CARD9 in WT and patient neutrophils and
CD14+ monocytes (Fig 1F), whereas, as expected, no significant CARD9 expression was
observed on T lymphocytes (S2 Fig). Similarly, immunoblot analyses for CARD9 on whole-cell
extracts of the patient neutrophils and CD14+ monocytes demonstrated that CARD9 protein
expression levels and molecular weight were similar with that of WT cells (Fig 1G). These data
are in agreement with previous reports in which nonsense mutations prevented the generation
of full-length CARD9 protein, whereas missense mutations did not predictably do so [7, 8, 12,
13].
We next sought to examine the functional consequences of the c.170G>Amutation by mea-
suring the production of pro-inflammatory cytokines and chemokines from peripheral blood
mononuclear cells (PBMCs) stimulated with either heat-killed C. albicans or LPS. Consistent
Fig 1. The autosomal recessive c.170G>ACARD9missense mutation results in impaired pro-inflammatory cytokine responses in PBMCs upon
fungal stimulation. (A)Grocott-Gomori methenamine-silver stain of the patient’s T12 vertebral body biopsy sample showing filamentous fungal elements
consistent withC. albicans that grew in culture (magnification, ×400). (B) Sagittal magnetic resonance image of the cervical spine showing leptomeningeal
enhancement (black arrows) and a C5-T1 syrinx (white arrow). (C) Sagittal magnetic resonance image of the brain showing an abscess (arrow). (D)
Sequencing chromatograms ofCARD9 at position 170 for the patient, her parents and a healthy donor control. (E) Pedigree of the patient with Candida
meningoencephalitis. The patient is indicated in black and by arrow and the genotype of CARD9 alleles is indicated below each family member. (F) FACS
histograms of CARD9 staining in neutrophils and CD14+ monocytes of healthy donors and the patient (n = 2). (G) Representative Western blots of CARD9
protein expression in neutrophils and CD14+ monocytes of healthy donors and the patient. GAPDH is shown as loading control (n = 3). (H-J) IL-1β, IL-6 and
TNFα production by healthy donor (n = 10) and patient (n = 4) PBMCs after 48 hours of stimulation with heat-killedC. albicans or LPS or after 48 hours
without stimulation (n = 4–8 independent experiments). Data is analyzed by MannWhitney U-test or unpaired t-test, where appropriate. **P < 0.01;
***P < 0.001. (K) Percentage of CD4+ IL-17A+ T cells (within CD4+ T-cells) of the patient and 9 healthy donors following stimulation with PMA/ionomycin,
assessed by FACS. All quantitative data represent mean ± SEM.
doi:10.1371/journal.ppat.1005293.g001
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with previously reported CARD9mutations [8, 12, 13], the c.170G>Amutation resulted in
dramatically decreased IL-1β, IL-6 and TNF-α production after 48 hours of stimulation with C.
albicans compared with 10 healthy donors, while cytokine production following LPS stimula-
tion was comparable in the patient and healthy donor PBMCs (Fig 1H–1J). Furthermore, the
production of GM-CSF, IFN-γ, IL-1α, IL-2, IL-10, CCL3, CCL4, CCL5, CCL7 and CXCL8 was
also found to be CARD9-dependent in human PBMCs following fungal stimulation, whereas
production of IL-4, IL-7, IL-15, IL-16, CCL2, CXCL1, CXCL2 and CXCL5 was CARD9-inde-
pendent (S3 Fig). Since decreased proportions of IL-17+ CD4+ T cells have been reported in
some, but not all, CARD9-deficient patients [7, 8, 10, 12, 13], we evaluated the production of
IL-17A by the patient’s CD4+ T cells following PMA/ionomycin stimulation ex vivo using
FACS, and found no impairment relative to 9 healthy donors (Fig 1K). Taken together, these
data show that the c.170G>Amutation results in the generation of full-length CARD9 protein
which exhibits impaired capacity for production of pro-inflammatory mediators upon fungal
stimulation.
Human Phagocytes Require CARD9 for Killing Fungal Yeasts but Not
Hyphae, which Are Present in Infected Tissue
Neutrophils and monocytes/macrophages are the critical cellular mediators of host defense
against systemic C. albicans infection [19, 22, 23]. Therefore, we next investigated the effects of
the c.170G>Amutation on the ability of neutrophils and monocytes to kill the two major mor-
phological forms of C. albicans, yeasts and hyphae. Hyphae are the invasive filamentous fungal
forms present in human infected CNS tissue (Fig 1A). It has been previously shown that
CARD9 deficiency impairs the killing capacity of neutrophils against unopsonized, but not
opsonized, C. albicans yeasts [7, 15]. Indeed, we found decreased killing by the patient’s neutro-
phils of unopsonized C. albicans yeasts whereas neutrophil killing was intact against opsonized
yeasts (Fig 2A). However, CARD9-deficient neutrophils did not exhibit impaired killing capac-
ity against opsonized or unopsonized C. albicans hyphae (Fig 2B), which are the predominant
form found in infected CNS tissue of mice and humans (Fig 1A) [24, 25]. We then examined
the impact of CARD9 deficiency on the ability of CD14+ monocytes to kill C. albicans yeasts
and hyphae. CD14+ monocytes demonstrated inferior killing capacity of C. albicans relative to
neutrophils (Fig 2A–2D). As shown in Fig 2C and 2D, CD14+ monocytes from the patient
exhibited a modest decrease in killing of C. albicans yeasts, but hyphal killing was intact. The
decreases observed in killing of yeasts by the patient’s neutrophils and CD14+ monocytes were
not due to impaired fungal internalization (Fig 2E). Collectively, these data show that although
CARD9-deficient neutrophils have a decreased ability to kill unopsonized C. albicans yeasts,
CARD9 is dispensable for killing of the invasive hyphal forms found in infected CNS tissue.
Therefore, other factors in addition to CARD9-mediated C. albicans yeast killing by phagocytes
are likely to also contribute to the susceptibility of CARD9-deficient patients to Candida infec-
tion of the CNS.
CARD9 Deficiency Results in a Striking Absence of Neutrophils in the
Infected CNS
Notably, we observed that the patient had a striking absence of neutrophils in the infected CSF,
despite uncontrolled fungal disease. Fig 3A shows a representative cytopathology image of the
infected CSF, in which lymphocytes, eosinophils and mononuclear phagocytes could be found,
but neutrophils were absent. Indeed, FACS analysis of the infected CSF revealed that the pre-
dominant accumulating leukocytes were T-lymphocytes and eosinophils (Fig 3B), which are
not critical mediators of host defense against systemic C. albicans infection [19]. This finding is
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in agreement with other reports of high numbers and predominance of lymphocytes and eosin-
ophils in the CSF of Candida-infected CARD9-deficient patients [7, 9]. Monocytes, dendritic
cells and B-cells were also present (5–10% each), whereas neutrophils comprised<1% of total
leukocytes (Fig 3B). Over time, the lack of neutrophils was consistent with these cells never
exceeding 7% of total leukocytes in the infected CSF (range: 0–7%) despite continued inflam-
mation (range of nucleated cells in CSF: 108-422/μl; range of % of eosinophils within leuko-
cytes in CSF: 3–40%; range of lymphocytes within leukocytes in CSF: 25–72%; range of protein
levels in CSF: 161–845 mg/dL) and extremely high fungal load indicated by persistently ele-
vated CSF BDG (Fig 3C). Persistent Candida tissue hyphal invasion and absence of neutrophil
infiltration were confirmed in the patient’s CNS tissue by brain biopsy (S4 Fig). The decreased
neutrophil accumulation noted in our patient is grossly suboptimal compared to the robust
neutrophil accumulation seen in patients without CARD9 deficiency when they develop C.
albicansmeningitis, typically post-neurosurgical procedures (Fig 3C; red bar) [26–29].
Fig 2. CARD9mediates killing ofCandida yeasts by human phagocytes but it is dispensable for the killing of invasiveCandida hyphal forms that
are found in infected tissue. Killing of opsonized and unopsonized Candida yeasts (A) and hyphal forms (B) by healthy donor and patient neutrophils
(n = 5–7). Killing of opsonized and unopsonized Candida yeasts (C) and hyphal forms (D) by healthy donor and patient CD14+ monocytes (n = 5–8). (E)
Internalization of opsonized (left panel) and unopsonized (right panel)Candida yeasts by healthy donor and patient neutrophils and CD14+ monocytes (n = 3
independent experiments). Data is analyzed by MannWhitney U-test or unpaired t-test, where appropriate. *P < 0.05; **P = 0.01; ***P < 0.001. All
quantitative data represent mean ± SEM.
doi:10.1371/journal.ppat.1005293.g002
Neutrophil Recruitment to the Fungal-Infected CNS Requires CARD9
PLOS Pathogens | DOI:10.1371/journal.ppat.1005293 December 17, 2015 7 / 32
Neutrophil Recruitment to the Fungal-Infected CNS Requires CARD9
PLOS Pathogens | DOI:10.1371/journal.ppat.1005293 December 17, 2015 8 / 32
Consistent with that, a patient at NIH who developed C. albicansmeningitis post-Ommaya
reservoir placement exhibited pleiocytosis (133–1091 nucleated cells/μl) and significant neu-
trophil mobilization in the infected CSF (56–73% of total leukocytes) (Fig 3C; grey bar).
We next sought to investigate the etiology of suboptimal neutrophil accumulation in the
infected CSF in the setting of CARD9 deficiency. The patient did not manifest peripheral neu-
tropenia (range of absolute neutrophil count in the blood: 1,960–5,340/mm3), ruling out this
possibility (Fig 3D). We next examined whether CARD9 is a survival factor for human neutro-
phils. For that, we harvested neutrophils from the peripheral blood of the patient and healthy
donors and determined differential cell apoptosis and death at 3 and 6 hours after serum star-
vation, TNF-α stimulation or live C. albicans challenge ex vivo. Neutrophils were also directly
exposed to the patient’s infected CSF to evaluate for the presence of potential soluble pro-apo-
ptotic factors within the infected tissue. We found that CARD9-deficient neutrophils did not
exhibit enhanced apoptosis or death under any of the tested conditions relative to WT neutro-
phils (Fig 3E). Therefore, these data demonstrate a striking absence of neutrophil accumulation
in the Candida-infected CSF in human CARD9 deficiency, which is not caused by peripheral
neutropenia or defective neutrophil survival.
CARD9 Is Critical for the Production of Neutrophil-Targeted
Chemoattractants in the Infected CSF
We reasoned that the decreased neutrophil recruitment in the CNS of the patient could be
explained by the net effect of (1) impaired intrinsic chemotactic ability of CARD9-deficient
human neutrophils and/or (2) defective production of neutrophil-targeted chemoattractants in
the infected tissue. Thus, we tested whether CARD9-deficient neutrophils have cell-intrinsic
chemotactic defects and/or whether the neutrophil-targeted chemoattractants are not pro-
duced in order to generate the chemotactic gradient that is necessary for cell trafficking into
the infected CNS. We first assessed neutrophil chemotaxis using both the EZ-TAXIScan system
and a modified Boyden chamber, the 96-well Neuroprobe chamber. The EZ-TAXIScan instru-
ment allows for simultaneous measurement of cell velocity and directionality by observing the
spatial and temporal movement of individual cells toward a chemoattractant. Using this
method, we found no defect in chemotaxis of CARD9-deficient neutrophils toward IL-8 or for-
myl-methionyl-leucyl-phenylalanine (fMLP) (Fig 4A and 4B), two prototypic chemotactic fac-
tors for human neutrophils. We then used the 96-well Neuroprobe chamber and examined
neutrophil chemotaxis toward IL-8, fMLP, the leukotriene B4 (LTB4), and the complement
factor C5a. Similar to our EZ-TAXIScan data, no impairment was found in the chemotaxis of
CARD9-deficient neutrophils relative to WT neutrophils using the 96-well Neuroprobe cham-
ber when correcting for multiple comparisons (Fig 4C).
Since the patient’s neutrophils did not exhibit a primary chemotaxis defect, we next mea-
sured levels of the neutrophil-targeted chemokines CXCL1, CXCL2, CXCL5 and IL-8 in the
infected CSF by Luminex array at different prospective time-points during uncontrolled fungal
infection. Strikingly, we found absent to very low levels of these chemokines (Fig 4D). IL-8 was
Fig 3. CARD9 deficiency results in a striking absence of neutrophils from the infected CSF that is not caused by peripheral neutropenia or
decreased neutrophil survival. (A) Representative cytopathology image of the patient’s infected CSF showing lymphocytes, eosinophils and mononuclear
phagocytes, but no neutrophils. (B) Immunophenotype of the patient’s infected CSF, assessed by FACS. (C) Percentages of neutrophils within leukocytes in
the CARD9-deficient patient’s infected CSF over time. The frequency range of neutrophils in the CSF found in our CARD9+/+ patient with Candidameningitis
post-Ommaya reservoir placement (grey bar) and those typically reported for Candidameningoencephalitis in patients without CARD9 deficiency (red bar)
are also shown. (D) The percentages of neutrophils within leukocytes in peripheral blood of the CARD9-deficient patient over time. (E)Healthy donor and
patient neutrophils were cultured for 3 hours (upper panels) or 6 hours (lower panels) under the indicated conditions and FACS used to assess the
percentage of Annexin V+ PI- apoptotic (left panels) and Annexin V+ PI+ dead (right panels) cells (n = 3–4; 3 independent experiments). All quantitative data
represent mean ± SEM.
doi:10.1371/journal.ppat.1005293.g003
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detected at higher levels (mean: 267.6 pg/mL) than all other chemokines (mean: 13.3 pg/mL
for CXCL1, 10.6 pg/mL for CXCL2, 16.3 pg/mL for CXCL5), but these IL-8 levels were compa-
rable to previously reported IL-8 levels in uninfected CSF from healthy donors [30]. Interest-
ingly, the measured levels of IL-8 are significantly lower than those detected in patients with
neutrophilic meningitis in the absence of CARD9 deficiency (Fig 4D; red bar) [30]. Consistent
with the absence of induction of neutrophil-targeted chemokines, CSF from the infected
patient did not exhibit any greater chemotactic activity toward WT and patient neutrophils
than that observed in buffer, CSF from a healthy subject or CSF from two patients with lym-
phocytic (non-neutrophilic) meningitis (Fig 4E).
Instead, our CARD9+/+ patient who developed C. albicansmeningitis post-Ommaya reser-
voir placement associated with neutrophil mobilization in the CSF exhibited significant induc-
tion of CXC neutrophil-recruiting chemokines in the infected CSF (Fig 4D; grey bar).
Specifically, the CSF levels of IL-8, CXCL1, CXCL2 and CXCL5 were 17.1–fold (4576.8 pg/
mL), 294.4–fold (3120.6 pg/mL), 16–fold (261.2 pg/mL) and 93.4–fold (1523.1 pg/mL) greater,
respectively, relative to those detected in the CSF of our CARD9-deficient patient. In line with
the induction of neutrophil-targeted CXC chemokines, Candida-infected CSF from the
CARD9+/+ patient exhibited chemotactic activity toward WT neutrophils ex vivo (Fig 4F).
Altogether, these data suggest that the absence of neutrophil accumulation in the infected CNS
despite uncontrolled fungal disease correlates with a defect at the level of chemoattractant pro-
duction in the infected tissue, whereas CARD9 is dispensable for cell-intrinsic neutrophil
chemotaxis.
Neutrophils Are Critical for Control of Fungal CNS Infection in Wild-Type
(WT) Mice
To further examine the mechanistic role of CARD9 in antifungal defense of the CNS, we uti-
lized a well-established mouse model of systemic C. albicans infection. This model results in
fungal dissemination to the brain associated with an early influx of neutrophils, whose accumu-
lation decreases later on as the infection is controlled [24]. To directly examine whether the
recruitment of neutrophils to the CNS is critical for control of fungal proliferation in this tissue,
we depleted neutrophils in WT mice using the 1A8 clone of the anti-Ly6G antibody [31]. We
found that administration of 1A8 successfully depleted>90% of neutrophils in the brain of
infected mice compared to infected mice treated with an isotype control antibody, and had no
effect on the recruitment of other myeloid cells such as Ly6Chi monocytes (Fig 5A). Analysis of
brain fungal burdens in these animals revealed that neutrophil depletion by 1A8 led to a signifi-
cant increase in brain fungal load compared to control animals (Fig 5B). Therefore, these data
demonstrate that neutrophil recruitment to the CNS post-infection is critical for control of fun-
gal brain infection.
Fig 4. CARD9 is critical for the generation of neutrophil-targeted chemokines in the infected CSF but it is dispensable for intrinsic chemotaxis of
human neutrophils. (A) Pooled data showing chemotaxis of healthy donor (n = 40) and patient (n = 2) neutrophils towards IL-8 (left panel) and fMLP (right
panel) assessed by the EZ-TAXIScan system. (B) EZ-TAXIScan data for individual neutrophils moving towards either IL-8 (left panels) or fMLP (right panels);
individual tracks are represented by different colours and were recorded over 1 hour. (C) Chemotaxis of healthy donor (n = 13–15) and patient (n = 2)
neutrophils towards fMLP, C5a, IL-8 and LTB4 at the indicated concentrations, assessed by the 96-well Neuroprobe chamber. Data is analyzed by two-way
ANOVA (with Bonferroni correction). (D) Levels of neutrophil-targeted chemokines in the CARD9-deficient patient’s infected CSF (n = 3). The range of IL-8 in
the CSF found in our CARD9+/+ patient withCandidameningitis post-Ommaya reservoir placement (grey bar) and previously reported for neutrophilic
meningitis in patients without CARD9 deficiency (red bar) are also shown. (E) The patient’s infected CSF is not chemotactic toward healthy donor and patient
neutrophils, as assessed by the 96-well Neuroprobe chamber (n = 2). Resting indicates neutrophil migration toward buffer; nd: not detected. (F) The CSF of
the CARD9+/+ Candida-infected patient post-Ommaya reservoir, but not the CSF of the CARD9-deficient patient, is chemotactic toward healthy donor
neutrophils, as assessed by the 96-well Neuroprobe chamber (n = 2–4). Resting indicates neutrophil migration toward buffer. **P < 0.01 by unpaired t-tests.
All quantitative data represent mean ± SEM. fMLP, formyl-methionyl-leucyl-phenylalanine; LTB4, leukotriene B4; PMNs, neutrophils.
doi:10.1371/journal.ppat.1005293.g004
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Fungal Infection of WT Mouse CNS Results in Chemokine Production
and Neutrophil Recruitment That Correlate with the Extent of Brain
Fungal Burden
We further analyzed the fungal-load dependence of the neutrophil response in the infected
WTmouse CNS by infecting WTmice with either a low (7x104) or a high (1x106) inoculum of
C. albicans. WT mice infected with the high inoculum developed significantly greater brain
fungal burden compared to those infected with the low inoculum (Fig 5C). Using FACS, we
assessed the number of recruited neutrophils in the brains of animals with high or low tissue
burden. We found that animals infected with the high inoculum, which developed high brain
fungal proliferation, had nearly 10-fold greater neutrophil numbers in the brain than observed
in the mice which received the low inoculum and had lower tissue fungal burden (Fig 5D).
Accordingly, we found that the levels of the major mouse neutrophil-targeted chemokines
Cxcl1 (KC) and Cxcl2 (MIP-2) were significantly increased in the brains of mice with the
higher tissue fungal burden (Fig 5E). In contrast, LPS-induced chemokine (LIX), the mouse
Fig 5. Neutrophil recruitment is critical for control of fungal brain infection and directly correlates with the extent of brain fungal burden in mice.
WT animals were injected intravenously with 100 μg of 1A8 antibody (red bars, n = 10) or 2A3 isotype control antibody (grey bars, n = 8) at 24 hours prior to
infection and at the time of infection. At 24 hours post-infection, brains from these mice were analyzed for (A) recruitment of myeloid cells by FACS and (B)
brain fungal burden. Data pooled from two independent experiments and analyzed by two-way ANOVA (A) or MannWhitney U-test (B). WT animals were
systemically infected with a low (7x104) or a high inoculum (1x106) of C. albicans SC5314 and brains assessed for (C) fungal burden, (D) neutrophil
recruitment by FACS and (E) production of neutrophil-targeted chemokines by Luminex array at 72 hours post-infection. Data shown is representative of 2
independent experiments and analyzed by unpaired t-tests (C-E). *P<0.05, **P<0.01, ***P<0.005, ****P<0.001. Data represent mean ± SEM.
doi:10.1371/journal.ppat.1005293.g005
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homologue of CXCL5 which can also recruit neutrophils, was similar in all brains analyzed and
had no correlation to the extent of brain fungal burden (Fig 5E), suggesting that Cxcl5 induc-
tion is not fungal-load dependent in the infected mouse brain. Taken together, these data show
that neutrophil-targeted chemokine production and neutrophil mobilization to the infected
CNS directly correlates with the extent of tissue fungal burden.
Card9 Is Required for CNS Neutrophil Accumulation and Control of
Fungal Brain Infection
We next sought to understand the functional role of Card9 in the mouse brain during C. albi-
cans infection. For this, we used Card9-/- mice that are significantly more susceptible to sys-
temic candidiasis (Fig 6A), as has been previously shown [6]. Importantly, we phenocopied for
the first time the human CNS susceptibility to Candida infection of CARD9-deficient patients
in Card9-/- mice which developed uncontrolled brain infection, evidenced by significantly
higher brain fungal burdens as early as 24 hours post-infection (Fig 6B). At 72 hours post-
infection, Card9-/- mice exhibited dramatically greater brain fungal burdens (over 1000-fold)
compared to WT animals. In agreement, histopathological analysis of infected brains revealed
Fig 6. Card9-/-mice are highly susceptible to candidiasis of the CNS and do not accumulate neutrophils into the infected brain. (A) WT (solid line,
n = 7) andCard9-/- (dotted line, n = 6) littermates were infected with 1x105 CFU SC5314C. albicansSC5314 yeasts intravenously and survival monitored for 14
days post-infection; data analyzed by log-rank (Mantel-Cox) test. (B) Brains were isolated fromWT (filled circles) andCard9-/- (empty circles) mice at 24 (WT
n = 12, KO n = 11) and 72 (WT n = 12, KO n = 10) hours post-infection and analyzed for fungal burden; data analyzed byMannWhitney U-test. (C) PAS-stained
brain sections fromWT andCard9-/-mice at 72 hours post-infection. Images were taken in the cerebrum region of the brain. Images are representative of 6
animals from 2 independent experiments. (D) Neutrophil numbers were determined by FACS in the brain of WT (filled bars, 0 hours n = 5, 24 hours n = 6–13, 72
hours n = 6–13) andCard9-/- (empty bars, 0 hours n = 5–6, 24 hours n = 6–14, 72 hours n = 6–12) mice; data analyzed by two-way ANOVA. (E) PAS-stained
brain sections fromWT andCard9-/-mice at 24 hours post-infection, analyzed as described in (C). (F) Neutrophil numbers in the peripheral blood, analyzed as
in (D). In B-F, mice analyzed at 24 hours were infected with 1.3x105 CFU SC5314, and mice analyzed at 72 hours were infected with 7x104 CFU. All data is
pooled from 2–4 independent experiments; data represent mean ± SEM. ***P<0.005, ****P<0.001.
doi:10.1371/journal.ppat.1005293.g006
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extensive tissue invasion in the Card9-/- brain by hyphae, which were the predominant fungal
morphology observed in the infected brain (Fig 6C).
Since our CARD9-deficient patient had limited numbers of neutrophils in the infected CSF,
we next investigated whether the same defect was present in the infected Card9-/- mouse brain.
Indeed, we found a profound decrease in neutrophil accumulation in the Card9-/- brain at 24
hours post-infection compared with WT animals (Fig 6D and S5A Fig). Notably, while WT
mice recruited high numbers of neutrophils to the brain early after infection, there was no sig-
nificant increase in neutrophil numbers or frequency between uninfected and infected Card9-/-
brains at any time point after infection, despite dramatic tissue fungal proliferation (Fig 6D
and S5A Fig). Indeed, histopathology revealed that neutrophils could be seen to crowd around
hyphae in WT brains at 24 hours post-infection, whereas very few of these cells were observed
in Card9-/- brains (Fig 6E). Card9-/- brains had similar neutrophil numbers with WT brains at
72 hours post-infection; strikingly, these numbers were similar to those observed in the unin-
fected brain (Fig 6D). This reflects a markedly defective response in Card9-/- mice since these
animals have over 1000-fold increase in brain fungal burden compared to WT (Fig 6B); hence,
based on the inoculum-dependence of neutrophil accumulation in the mouse brain (Fig 5),
these animals should have mobilized significantly more neutrophils into this tissue. In our
patient and in other reported patients’ CSF [7, 9], in addition to a lack of neutrophils, we and
others also observed high numbers of lymphocytes and eosinophils. To investigate if this was
also true in Card9-/- mice, we calculated the relative frequency of multiple lymphoid and mye-
loid cell populations in the brain following infection by FACS. Besides a significant reduction
in neutrophils and a corresponding increase in microglia percentages in Card9-/- brains, we did
not find any other significant differences in the frequency of other leukocyte populations
between WT and Card9-/- brains at the tested time points (S5B Fig). Collectively, these data
show that, consonant to human findings, Card9 is required for the control of C. albicans infec-
tion of the CNS and for promoting neutrophil accumulation in the infected brain.
Card9 Mediates Tissue-Specific and Fungal-Specific Neutrophil
Accumulation into the Infected CNS
We next investigated whether neutrophil accumulation into the C. albicans-infected kidney is
Card9-dependent. We found that, in line with previously reported findings [6], Card9-/- mice
had significantly increased kidney fungal burdens at both 24 and 72 hours post-infection (S6A
Fig). However, unlike the brain, Card9-/- mice were able to mobilize significant numbers of
neutrophils into the kidney at 72 hours post-infection, approximately 3-fold greater than in
WT infected kidneys at the same time-point post-infection, and nearly 100-fold greater than in
uninfected control kidneys (S6B Fig). Although the extent of neutrophil accumulation may still
be to a degree suboptimal relative to the higher kidney fungal load seen in Card9-/- kidneys [22,
24, 32], the data collectively indicate that Card9 plays organ-specific roles in neutrophil accu-
mulation after systemic candidiasis, in agreement with a recent report showing neutrophil
mobilization into the C. tropicalis infected Card9-/- kidney [33].
We then assessed whether the defect in neutrophil accumulation into the infected brain was
specific to fungi or could be recapitulated with non-fungal pathogens. For this, we infected WT
and Card9-/- animals intravenously with Staphylococcus aureus, an important human bacterial
pathogen. We found that Card9-/- mice had similar bacterial burdens and accumulation of neu-
trophils in the brain compared to WT mice at 48 hours post-infection (S7 Fig). These data are
in agreement with the lack of development of bacterial CNS infections in patients with CARD9
deficiency and show that the neutrophil accumulation defect we observed during C. albicans
infection is specific for fungal pathogens.
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Card9 Is Not Required for Neutrophil Production and Egress from Bone
Marrow
We next began to investigate possible mechanisms of the Card9-dependent accumulation of
neutrophils in the brains of C. albicans infected mice. We first assessed whether Card9 is criti-
cal for the production of neutrophil progenitors in the bone marrow and egress of these cells
into the peripheral blood after infection. We found that C. albicans infection led to a significant
increase in neutrophil progenitors in the bone marrow (S8 Fig) and a significant induction of
neutrophilia in the blood of WT mice (Fig 6F). No differences were observed in neutrophil
numbers in the bone marrow (S8 Fig) and peripheral blood (Fig 6F) between WT and Card9-/-
animals, either at steady state or after infection. Since neutrophil production and mobilization
of large numbers of neutrophils from the bone marrow into the blood of Card9-/- mice follow-
ing C. albicans infection did not translate into accumulation of these cells into the infected
CNS (Fig 6D–6F), these data collectively suggest that Card9 is critical for the trafficking of neu-
trophils from the blood into the infected CNS.
Card9-/- Neutrophils Exhibit Normal Chemotaxis, Adhesion and Survival
In Vivo
We showed earlier that CARD9-deficient human neutrophils had normal chemotaxis toward
four major neutrophil-targeted chemoattractants ex vivo (Fig 4A–4C). To analyze the recruit-
ment of WT and Card9-/- neutrophils into the fungal-infected CNS in vivo, we generated
mixed bone marrow chimeras in order to directly assess whether Card9-/- neutrophils have a
cell-intrinsic chemotactic defect. WT animals were lethally irradiated and subsequently
injected with a 1:1 ratio of CD45.1+ WT and CD45.2+ Card9-/- bone marrow cells. Following
the adoptive transfer, animals were left to reconstitute for 8 weeks prior to C. albicans infection
(S9 Fig). The relative recruitment of WT and Card9-/- neutrophils to the brain of infected chi-
meras was then assessed by FACS, with congenic CD45 isoform expression used to distinguish
between WT and Card9-/- neutrophils. Using this approach, we found no defect in the ability
of Card9-/- neutrophils to traffic into the infected brain, since the relative ratio of WT:Card9-/-
neutrophils remained unchanged before and after infection (Fig 7A). These data indicate that
neutrophil-intrinsic Card9 is dispensable for neutrophil recruitment during fungal infection of
the CNS.
The mixed chimera experiment results (Fig 7A) implied that Card9-/- neutrophils are able to
upregulate key adhesion molecules that allow their transmigration from the blood into the
infected brain. To further test this, we next analyzed whether expression of various adhesion
molecules that are required for neutrophil adhesion and rolling on the endothelial surface for
transmigration into inflamed tissues was disrupted in the absence of Card9. Using qRT-PCR
on whole brain homogenates, we found that all adhesion molecules analyzed were induced in
the brain of WT mice following infection (Fig 7B). While we observed a delayed induction in
the expression of α-integrin X and α-integrin L in infected Card9-/- brains, these differences
were not evident at 72 hours post-infection. Since β-integrin 2 induction was greater in
Card9-/- brains at 72 hours post-infection, we assessed whether its induction in the Candida-
infected brain is fungal load-dependent by infecting WT mice with high and low brain fungal
burdens. Indeed, induction of β-integrin 2, ICAM-1 and L-selectin was significantly greater in
animals with higher brain fungal burden, whereas induction of α-integrin X, α-integrin L and
P-selectin was not fungal load-dependent (S10 Fig). These data suggest that the higher levels of
β-integrin 2 and the trend toward higher induction of ICAM-1 observed in Card9-/- brains
(Fig 7B) may reflect greater tissue fungal proliferation in these mice. Collectively, we did not
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observe consistent or profound defects in the expression of neutrophil-targeted adhesion mole-
cules in the infected Card9-/- brain (Fig 7B).
The mixed chimera experiment results (Fig 7A) also suggested that Card9-/- neutrophils do
not have a survival defect in vivo. To directly rule out the possibility that reduced neutrophil
numbers in the Card9-/- brain is caused by enhanced neutrophil apoptosis and/or death follow-
ing their recruitment into the CNS, we analyzed the extent of apoptosis and death in neutro-
phils recruited to the brain at 24 hours post-infection using Annexin-V and 7-AAD staining.
We found that the frequency of apoptotic and dead neutrophils was similar in WT and
Card9-/- brains (Fig 7C), in line with our patient data that showed that CARD9 is not a survival
factor in human neutrophils (Fig 3E).
Taken together, these data show that Card9 deficiency does not adversely affect cell-intrinsic
neutrophil trafficking to the brain, expression of neutrophil-targeted adhesion molecules, or
neutrophil survival during C. albicans infection of the CNS in mice.
Fig 7. CARD9 deficiency does not affect cell-intrinsic neutrophil chemotaxis, survival or expression of adhesionmolecules. (A) The ratio of
CD45.1+ WT neutrophils to CD45.2+ Card9-/- neutrophils in mixed bone marrow chimeras was determined by FACS in the blood prior to infection and in the
blood and brain at 24 (left panel) and 72 hours (right panel) post-infection (n = 7–8 per time point). (B) Expression of various adhesion molecules in whole
brain homogenates of uninfected and infectedWT (filled bars, n = 6) andCard9-/- (empty bars, n = 6) mice, as determined by qRT-PCR. Gene expression
was calculated relative to Gapdh. Mice analyzed at 24 hours were infected with 1.3x105 CFU SC5314, and mice analyzed at 72 hours infected with 7x104
CFU. (C) Neutrophil survival in the brain of 24-hour infected (dose: 1.3x105 CFU)WT (filled bars, n = 6) andCard9-/- (empty bars, n = 6) mice was determined
by Annexin-V and 7-AAD staining and analysis by FACS. Apoptotic neutrophils were defined as Annexin-V+ 7-AAD-, while dead neutrophils were defined as
Annexin-V+ 7-AAD+. All data is pooled from two independent experiments; data represent mean ± SEM. *P<0.05 by two-way ANOVA.
doi:10.1371/journal.ppat.1005293.g007
Neutrophil Recruitment to the Fungal-Infected CNS Requires CARD9
PLOS Pathogens | DOI:10.1371/journal.ppat.1005293 December 17, 2015 16 / 32
CARD9 Is Required for Neutrophil-Targeted Chemokine Production in
the Infected CNS
Since Card9-/- neutrophils did not exhibit a cell-intrinsic chemotactic defect, and as we found
our patient’s infected CSF to contain low concentrations of neutrophil-targeted CXC chemo-
kines, we next investigated if this defect could also be modeled in the brains of Card9-/- mice.
Thus, we analyzed whole brain homogenates for expression of Cxcl1, Cxcl2 and Cxcl5 by
Luminex array in uninfected and C. albicans-infected mice. We found that both Cxcl1 and
Cxcl2 were significantly induced following infection in both WT and Card9-/- mice whereas
Cxcl5 was poorly induced (S11 Fig). At 24 hours post-infection, WT and Card9-/- brains had
similar levels of these chemokines despite a 10-fold higher fungal load in Card9-/- brain tissue
(S11 Fig). At 72 hours post-infection, chemokine levels decreased in WTmice in parallel with
falling tissue fungal burden (Fig 6B), whereas chemokine levels in Card9-/- brains remained sta-
ble relative to 24 hours post-infection (S11 Fig) despite a further dramatic increase in brain
fungal burden (Fig 6B). When chemokine production was expressed as a concentration relative
to fungal load, Cxcl1 and Cxcl2 levels were dramatically decreased in Card9-/- brains (Fig 8A).
We then examined CXC chemokine induction in the kidney and found that Cxcl1 and
Cxcl2 were significantly increased in the infected Card9-/- kidneys compared to WT (S6C Fig).
Although induction of Cxcl1 and Cxcl2 was to a degree impaired relative to the kidney fungal
load in Card9-/- mice (S6A and S6C Fig), renal CXC chemokine induction was sufficient for
mediating neutrophil recruitment into the Candida-infected Card9-/- kidney (S6B Fig). Since
the IL-17/IL-22 pathway has also been shown to promote neutrophil recruitment into infected
tissues [34], and some CARD9-deficient patients have reduced Th17 cells in the peripheral
blood [7, 9, 13], we determined the levels of IL-17 and IL-22 in the brains of WT and Card9-/-
mice following infection. However, we found no consistent induction of these cytokines com-
pared to uninfected control brain, at either the mRNA or protein levels. Taken together,
Card9-/- mice display a marked insufficiency in the induction of Cxcl1 and Cxcl2 in the brain
during C. albicans infection relative to the extent of tissue fungal burden.
Neutrophils and CD45- Cells Produce Neutrophil-Targeted
Chemoattractants in a Card9-Dependent Manner
Since we identified that CXC chemokines were reduced in the CNS of both mice and humans
with CARD9 deficiency, we next sought to understand the cellular source of these chemokines
in a bid to further define the antifungal immune response within the brain. We used FACS-
sorting (S12 Fig) to purify the major recruited myeloid cell populations from infected brains
(neutrophils and Ly6Chi monocytes), and then used qRT-PCR to quantify relative expression
of Cxcl1, Cxcl2 and Cxcl5. We also FACS-sorted and analyzed resident cell populations from
infected brains, as microglia and astrocytes have been shown to be major producers of cyto-
kines and chemokines during CNS inflammation [35–37]. Firstly, we found that all cell
populations expressed Card9, with the highest levels detected in resident microglia (Fig 8B).
Interestingly we also found low, albeit detectable, expression of Card9 in the CD45- population
(Fig 8B), which is predominantly made up of resident glial cells as determined by the presence
of transcripts for glial acidic fibrillary protein (Gfap; astrocyte marker) and myelin oligoden-
drocyte glycoprotein (Mog; oligodendrocyte marker), while endothelial cells were absent as
determined by CD31/CD102 staining (S12C and S12D Fig). We found that neutrophils were
the major cellular source of Cxcl2 in the infected brain in WT animals, while CD45- cells pre-
dominantly produced Cxcl1 and Cxcl5 (Fig 8C). In infected Card9-/- brains, we found a signifi-
cant decrease in levels of Cxcl1 and Cxcl2 from purified Card9-/- neutrophils, and further
profound decreases in Cxcl1 and Cxcl5 in the Card9-/- CD45- population (Fig 8C).
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Fig 8. CARD9 is required for neutrophil-targeted chemokine production during fungal infection of the CNS. (A) Whole brain homogenates were
analyzed for Cxcl1, Cxcl2 and Cxcl5 in WT (filled bars, n = 6) andCard9-/- (empty bars, n = 6) mice by Luminex array. Chemokine concentration (ng/g) was
expressed relative to the mean brain fungal burden (CFU/g). Mice analyzed at 24 hours were infected with 1.3x105 CFU SC5314, and mice analyzed at 72
hours infected with 7x104 CFU. Data is pooled from two independent experiments and analyzed by two-way ANOVA (with Bonferroni correction). (B)
Relative expression ofCard9mRNA by indicated cell populations FACS-sorted fromWT brains at 24 hours post-infection (n = 3). (C) Neutrophils, Ly6Chi
monocytes, microglia and CD45- cells were FACS-sorted fromWT andCard9-/- brains at 24 hours post-infection (inoculum: 1.3x105) and RNA purified for
qRT-PCR analysis of Cxcl1, Cxcl2 andCxcl5 expression. See S11 Fig for purity analysis. Data is pooled from nine (neutrophils, Ly6Chi monocytes,
microglia) or six sorts (CD45- cells) and analyzed by two-way ANOVA (with Bonferroni correction). (D) Transgenic Cxcl2-GFP reporter animals (black
histograms) were infected with 1.3x105 CFU and brain leukocytes analyzed by FACS at 24 hours post-infection. Expression of GFP within the indicated cell
populations was compared to non-transgenic WT animals (grey histograms). Histograms are representative of two independent experiments. (E)
Quantification of the frequency of GFP+ cells within the indicated cell populations and (F) percentage of GFP+ neutrophils within the WT andCard9-/- brain;
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To visualize the cellular sources of Cxcl2 in the Candida-infected brain in vivo, we made use
of a recently described transgenic Cxcl2-GFP reporter mouse [38]. In line with our qRT-PCR
data, we found that neutrophils in the infected WT brain were the predominant producers of
Cxcl2 following infection, whereas Cxcl2 was undetectable in other tested cell populations (Fig
8D and 8E). When we infected Card9-/- mice on this genetic background (Card9-/- Cxcl2-GFP),
we found decreased proportion of Cxcl2-expressing Card9-/- neutrophils in the infected brain
(Fig 8F). Thus, our data indicate that resident CD45- cells and recruited neutrophils are the
major producers of neutrophil-targeted CXC chemokines in the C. albicans-infected mouse
brain. Taken together, because CNS tissue does not contain large numbers of resident neutro-
phils at steady state, our data are consistent with a model by which an early wave of Card9-de-
pendent chemotactic signals by resident cells is followed by a subsequent positive feedback
loop of neutrophil-driven cell chemoattraction that is defective in the Card9-/- brain.
Discussion
In the present study, we show that the antifungal adaptor molecule CARD9 is critical for neu-
trophil recruitment from the blood into the CNS during fungal infection in mice and humans.
CARD9 appears to act by promoting production of neutrophil-targeted chemoattractants in
the infected CNS tissue, while cell-intrinsic neutrophil chemotaxis is CARD9-independent.
Our conclusions are based on detailed analysis of differences in clinical, microbiological, patho-
logical, immunological and molecular parameters between Card9+/+ and Card9-/- mice, and are
corroborated by analogous functional defects identified in a CARD9-deficient patient with
Candidameningoencephalitis. Our study is the first to uncover the crucial role of CARD9 on
neutrophil accumulation in the CNS during systemic fungal infection in mice and humans,
and provides novel insight into the mechanisms of spontaneous susceptibility to CNS fungal
infection seen in autosomal recessive CARD9 deficiency.
Here, we describe a novel CARD9missense mutation, c.170G>A (p.R57H), which further
adds to the list of CARD9mutations associated with the development of systemic fungal infec-
tions [7–14, 18]. Multiple missense and nonsense CARD9mutations have now been described
that reside in both the coiled-coil and CARD domains [7–14]. There has been thus far no cor-
relation between specific CARD9mutations and development of systemic fungal infections,
and therefore more research will be required to define the potential differential functional roles
of the coiled-coil and CARD domains of CARD9 on promoting mucosal versus systemic
immunity against C. albicans and other fungi.
Despite several reports of CARD9-deficient patients with CNS infections, the mechanisms
of susceptibility in these patients are not well understood, which prompted us to investigate
phagocyte function, since these cells are required components of systemic antifungal immune
defense against Candida species [24]. We found that monocytes from the CARD9-deficient
patient had a profound defect in pro-inflammatory cytokine production specifically in
response to fungal components, similar to other reported findings [7–14]. In addition, we show
for the first time a modest, yet significant, defect in killing of C. albicans yeasts by monocytes,
the mechanisms of which merit future investigation. Similarly, in agreement with a previous
report [7], we found a defect in killing of unopsonized yeasts by CARD9-deficient human neu-
trophils, although opsonization could restore this defect. We found no impact of CARD9 defi-
ciency on the killing of hyphal C. albicans forms by either neutrophils or monocytes. These
results confirm recently reported findings using CARD9-deficient neutrophils from a patient
nd: not detected. Data pooled from two independent experiments (n = 5) and analyzed by unpaired t-tests; data represent mean ± SEM. *P<0.05, **P<0.01,
***P<0.005, ****P<0.001.
doi:10.1371/journal.ppat.1005293.g008
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infected with Phialophora, in which only killing of unopsonized conidia was defective, while
hyphal killing was intact [14]. Collectively, the impaired killing of CARD9-deficient neutro-
phils against unopsonized Candida yeasts has led to the hypothesis that CARD9 deficiency
may predispose humans to CNS infection since opsonization is suboptimal in this tissue. How-
ever, because the predominant Candidamorphology in the infected brain in mice and humans
is hyphae (Fig 1A, Fig 6C and S4 Fig) [9, 24], and because phagocyte hyphal killing is intact in
these patients, this current explanation appears insufficient to fully account for why these
patients develop spontaneous CNS fungal disease.
Strikingly, we found that CARD9 deficiency resulted in a profound absence of neutrophils
in the infected CNS (Fig 3, Fig 6 and S4 Fig); instead, eosinophils and lymphocytes were the
predominant leukocytes in the infected CSF, in agreement with recently published findings in
other CARD9-deficient patients with Candida CNS infection [7, 9]. This profound lack of neu-
trophil accumulation in the infected CNS is in stark contrast to the robust accumulation of
neutrophils in the Candida-infected CNS of mice and humans without CARD9 deficiency [24,
29, 39]. In our CARD9-deficient patient, this CNS-specific neutropenia could not be explained
by a decrease in circulating neutrophils or neutrophil survival, nor a cell-intrinsic chemotaxis
defect. Instead, we found that neutrophil-targeted CXC chemokines were not induced in the
infected CSF. In patients with neutrophilic meningitis, levels of IL-8 in the CSF have been
reported to reach up to 45,000 pg/mL (median, 13,900 pg/mL) [30], and the infected CSF has
been shown to be chemotactic toward neutrophils ex vivo [40]. Instead, our patient’s CSF
lacked chemotactic activity toward neutrophils ex vivo and had approximately 300 pg/mL of
IL-8, which is within the range of concentrations seen in the CSF of uninfected control individ-
uals [30], and less than 20 pg/mL of CXCL1, CXCL2 and CXCL5. This is in contrast to the
induction of CXC chemokines in the Candida-infected CSF of another patient without CARD9
deficiency who developed meningitis post-Ommaya reservoir placement at NIH, whose CSF
was chemotactic toward neutrophils ex vivo. Therefore, our data indicate that CARD9 is
required for proper production of these chemoattractants in response to CNS fungal infection.
However, more work assessing CSF leukocyte immunophenotype and measuring these che-
moattractants in the CSF of additional patients with CNS fungal infections, with and without
CARD9-deficiency, is needed.
To directly examine the role of CARD9 in CNS antifungal defense, we moved to a mouse
model of systemic candidiasis using Card9-/- mice [41]. We show for the first time that these
animals develop significant brain fungal infection with a profound absence of neutrophil accu-
mulation in the infected CNS. Furthermore, we also found that Card9-/- neutrophils could
mobilize from the bone marrow into the blood, thus demonstrating a Card9-dependent defect
of cell trafficking from the blood into the CNS, which is tissue- and fungus-specific. In line
with our human data, we showed that Card9-/- neutrophils did not have a survival defect nor
were they intrinsically defective in trafficking from the blood into the Candida-infected brain,
since they were able to mobilize into WT brains in mixed bone marrow chimera experiments.
Since our human data suggested that neutrophil-targeted chemokine production depended
on CARD9, we investigated the production and source of these molecules in the infected CNS
using our mouse model. We found that production of neutrophil-targeted chemokines was
grossly suboptimal in the Card9-/- brain relative to the tissue fungal burden. These data suggest
that the lack of neutrophils in the Card9-deficient CNS is caused, at least in part, by impaired
chemoattractant production. Recent work has demonstrated dependency on both Card9 and
IL-1R/Myd88 signaling for neutrophil-targeted chemokine production and neutrophil accu-
mulation in the Aspergillus-infected mouse lung [38, 42]. Specifically, Card9-/- mice infected
with Aspergillus recruited normal numbers of neutrophils to the lung in the early phase of the
infection driven via IL-1R/Myd88–dependent CXC chemokine production, whereas at the
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later stages of the infection a 40% decrease in neutrophil accumulation was observed, which
was due to decreased CXC chemokine production by Card9-/- hematopoietic cells [38, 42]. In
stark contrast to this partial dependency on Card9 for neutrophil recruitment during pulmo-
nary aspergillosis, we show here that Card9 deficiency almost abolishes neutrophil recruitment
to the CNS throughout the entire course of C. albicans infection. Taken together, these data
further underscore the tissue-specific nature of antifungal innate immune responses [24] and
provide a potential explanation why CARD9-deficient patients, including our patient reported
here, have not been reported to have increased susceptibility to pulmonary infections with
ubiquitous inhaled molds.
We next investigated the cellular source of neutrophil-targeted chemokines in the CNS, in a
bid to further understand how neutrophils are recruited to this site during fungal infection. We
found that neutrophils were the predominant source of Cxcl2 and to a lesser extent of Cxcl1, in
agreement with previous reports that neutrophils can create positive-feedback loops for their
continued recruitment into fungal-infected tissue [32]. We next investigated if Card9 was
required for this phenomenon, and found that Card9-/- neutrophils produced less Cxcl1 and
Cxcl2. Interestingly, we also found significant decreases in Cxcl1 and Cxcl5 transcript levels in
the CD45- resident cell population purified from Card9-/- brains, which we found were positive
for transcripts encoding glial markers Gfap andMog. Therefore, our data point to a two-step
chemokine-driven neutrophil recruitment process in the WT CNS, initially promoted by resi-
dent stromal cells and followed by cell-intrinsic neutrophil chemokine production. In Card9-/-
brains, an initial ‘hit’ of defective chemokine production by the resident CD45- compartment
may lead to poor neutrophil recruitment, which appears to be further exacerbated by the
absence of neutrophil-mediated Cxcl1 and Cxcl2 production in the Card9-/- brain.
Future studies should also aim to examine other neutrophil-targeted chemoattractants that
may also contribute to Card9-dependent neutrophil recruitment into the infected CNS, as well
as their myeloid and non-myeloid cellular sources and their Card9-dependent organ-specific
localization in tissue. In particular, our work has indicated that the resident cells in the brain
are integral for neutrophil-targeted chemokine production, and their identification and
Card9-dependent functions within antifungal immunity is an area of ongoing investigation in
our laboratory. Additionally, future work should also focus on whether CARD9 is equally criti-
cal for neutrophil recruitment to the CNS in CARD9-deficient patients and mice infected with
other fungal pathogens, such as the recently reported Exophiala [10].
In summary, we have identified a novel critical role for CARD9 in tissue- and fungus-spe-
cific neutrophil recruitment to the CNS during C. albicans infection in mice and humans.
CARD9 is important for the production of chemoattractants in the CNS by neutrophils and
resident cells, whereas other neutrophil-intrinsic functions such as phagocytosis, oxidative
burst, killing, chemotaxis and survival, appear largely CARD9-independent. Our work high-
lights the importance of the CLR/CARD9 immune pathway in the neutrophil-dependent con-
trol of C. albicans infection of the CNS, and forms the foundation for devising immune-based
therapies for bypassing CARD9 in the production of neutrophil-targeted chemokines such as




The patient, her relatives and the healthy donors were enrolled in protocols approved by the
National Institute of Allergy and Infectious Diseases and National Cancer Institute Institu-
tional Board Review (IRB) committees, and provided written informed consent for
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participation in the study. This study was conducted in accordance with the Helsinki Declara-
tion. Animal studies were performed in accordance with the recommendations in the Guide
for the Care and Use of Laboratory Animals of the National Institutes of Health, under the aus-
pices of protocol LCID14E approved by the Animal Care and Use Committee of the National
Institute of Allergy and Infectious Diseases. Animals were euthanized by cervical dislocation
following administration of ketamine/xylazine cocktail.
Isolation of DNA and CARD9 Sequencing
DNA was harvested from Ammonium-Chloride-Potassium (ACK)-lysed whole blood from
the CARD9-deficient patient, her parents and two siblings using the Gentra Puregene Blood
DNA isolation Kit (Qiagen) per the manufacturer’s instructions. Genomic amplification was
performed in 15 μL reactions using Platinum PCR SuperMix High Fidelity (Life Technologies),
0.625 mM of each primer and 10–200 ng of DNA. Cycling conditions were 95°C for 3 minutes
followed by 35 cycles of 95°C for 20 seconds, and 68°C for 2:45. PCR products were purified
using ExoSAP-IT (USB products by Affymetrix), sequenced using Big Dye Terminators v3.1
(Life Technologies), cleaned up using Performa DTR Ultra spin plates and run on an ABI
3730XL. Amplification and sequencing primers are shown in S1 Table.
Isolation of Human PBMC, CD14+ Monocytes and Neutrophils from
Peripheral Whole Blood
PBMC were harvested from whole blood by gradient centrifugation using Lymphocyte Separa-
tion Media (Lonza), according to the manufacturer’s instructions. PBMC were washed in PBS
and quantified prior to use in stimulation assays and flow cytometry (see below) or down-
stream sorting of CD14+ monocytes. CD14+ monocytes were magnetically sorted using nega-
tive selection via the Monocyte Isolation Kit II (Miltenyi) according to the manufacturer’s
instructions. Purity and viability of sorted monocytes was>84% and>92%, respectively. Neu-
trophils were isolated using 3% Dextran in 0.85% sodium chloride and red blood cells lysed
using sequential exposure to 0.2% and 1.6% NaCl solutions. Purity and viability of isolated
neutrophils exceeded 95%. CD14+ monocytes and neutrophils were quantified prior to use in
FACS or Western blot analyses or downstream functional assays, including internalization
assays, killing assays, survival studies and chemotaxis studies (see below).
Quantification of Immune Cells in the Infected CSF by FACS Analysis
CSF was centrifuged and cells were washed, then stained with a Live/Dead fluorescent dye
(Invitrogen) for 10 minutes in PBS at 4°C, followed by Fc receptor blockade with Fc Blocking
Reagent (Miltenyi) in FACS buffer (PBS supplemented with 0.5% BSA and 0.01% sodium
azide) at 4°C. Surface antigen staining was then performed by incubating cells with fluoro-
chrome-conjugated (eFluor 605 NC, PE-Cy7, APC, APC-eFluor 780, Alexa Fluor 700, eFluor
450, FITC, PE, PerCP-Cy5.5, Biotin/Streptavidin Brilliant Violet 570) antibodies against
human CD45 (HI30), CD56 (CMSSB), CD3 (SK7), CD19 (HIB19), CD11b (ICRF44), CD11c
(3.9), CD123 (6H6) (eBioscience); CD14 (M5E2), CD16 (3G8), HLA-DR (G46-6) (BD Biosci-
ences); CD141 (M80) (BioLegend) for 30 minutes on ice. After incubation, the cells were
washed 3 times with FACS buffer and sample acquired using a 5-laser BD LSRFortessa,
equipped with BD FACS Diva software (BD Biosciences). FlowJo (TreeStar) was used for the
final analysis. Cell numbers were quantified using PE-conjugated fluorescent counting beads
(Sperotech).
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PBMC Stimulation and Cytokine Determination by Luminex Array
To determine whether CARD9 deficiency affects the ability of PBMCs to produce pro-inflam-
matory cytokines and chemokines, we used a Luminex-based assay. In brief, 5 x 105 PBMCs
from healthy donors or the CARD9-deficient patient were incubated in duplicate in a round-
bottom 96-well plate (Corning Inc.) at 37°C in a 5% CO2 incubator in RPMI 1640 containing
10% fetal bovine serum (FBS, Gibco), 100 U/mL of penicillin, and 100 μg/mL of streptomycin
(unstimulated), or RPMI 1640 with 10% FBS/antibiotics containing LPS (100 ng/mL), or heat-
killed C. albicans SC5314 yeasts (1 x 106 /mL). After 48 hours of stimulation, PBMCs were pel-
leted and the supernatant was collected and stored at -80°C until analysis. Luminex analysis
was done via a multiplex bead array assay with antibodies and cytokine standards to generate
known concentration curves (R&D Systems, Peprotech). Individual Luminex bead sets
(Luminex) were coupled to cytokine-specific capture antibodies according to manufacturer’s
protocols and biotinylated polyclonal antibodies were used at twice the recommended concen-
trations for a classical ELISA according to the manufacturer’s instructions. The assay was run
with 1200 beads per set of cytokines in a volume of 50 μL. The plates were read on a Luminex
MAGPIX platform where more than 50 beads were collected per bead set. The median fluores-
cence intensity of the beads was then measured for each individual bead, which was analyzed
with the Millipex software using a 5P regression algorithm.
Candida Internalization by Human Neutrophils and CD14+ Monocytes
To determine whether CARD9 deficiency affects the capacity of peripheral blood neutrophils
and/or CD14+ monocytes to internalize C. albicans, 5 x 104 cells from healthy donors or the
CARD9-deficient patient were incubated in a polystyrene round-bottom FACS tube (BD Fal-
con) in a 37°C shaking water bath for 60 minutes in RPMI 1640 containing 100 U/mL of peni-
cillin and 100 μg/mL of streptomycin with dTomato-expressing Candida that had been
suspended in RPMI 1640 with antibiotics without (unopsonized) or with 5% human serum
(opsonized) at a cell:yeast ratio of 1:25 or 1:1, respectively. Samples were then stained with a
FITC-conjugated anti-Candida antibody (cat #21164; Abcam) and APC-conjugated anti-
CD14 (for monocytes) or anti-CD15 (for neutrophils) antibodies and subsequently washed.
FACS was performed on a 5-laser LSRFortessa. The percentage of Candida internalization by
myeloid cells was then determined by initially gating on APC+ monocytes or neutrophils and
then by defining the percentage of APC+ cells that had internalized Candida (APC+PE+FITC-)
versus those that had Candida bound on the cell surface (APC+PE+FITC+).
Candida Killing by Human Neutrophils and CD14+ Monocytes
To determine whether CARD9 deficiency affects the capacity of peripheral blood neutrophils
and/or CD14+ monocytes to kill Candida, we used the alamarBlue-based fluorescence assay as
previously described [22]. Briefly, neutrophils and monocytes were harvested from peripheral
blood as described above, and 5 x 104 cells from healthy donors or the CARD9-deficient patient
were incubated in flat-bottom 96-well plates (Genesee Scientific) for 2.5 hours with opsonized
or unopsonized Candida yeasts or 3-hour pre-grown pseudohyphae at a cell:Candida ratio
ranging from 1:4 to 4:1 (see figure legends). The wells were then treated with 0.02% Triton X-
100 in water to lyse the neutrophils/monocytes, washed twice with PBS and incubated with 1x
alamarBlue (Invitrogen) in PBS for 18 hours at 37°C. Fluorescence was measured using a
POLARstar OPTIMA plate reader (BMG Labtech). Killing was calculated by comparing the
fluorescence of Candida incubated with neutrophils or monocytes with that of Candida incu-
bated without myeloid cells.
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Survival Studies of Human Neutrophils
Neutrophils from healthy donors and the CARD9-deficient patient were harvested as described
above. To determine whether CARD9 deficiency impairs survival of neutrophils, cells were cul-
tured for 3 or 6 hours at 37°C in a 5% CO2 incubator in RPMI 1640 without FBS (serum starva-
tion) or in RPMI 1640 with 10% FBS with tumor necrosis factor-α (50 ng/mL) or live Candida
albicans SC5314 (1 x 105 cells/mL) or in infected CSF from the CARD9-deficient patient to
assess the extent of cell apoptosis and death. Cells were stained with Annexin V and propidium
iodide (BD Biosciences) per the manufacturer’s instructions, and flow cytometry was per-
formed on a 5-laser LSRFortessa.
Chemotaxis Assays of Neutrophils
Chemotaxis assays were performed on freshly isolated neutrophils using the EZ-TAXIScan
(ECI, Inc., Japan) or a modified Boyden chamber (NeuroProbe). In brief, 5 x 103 neutrophils
were placed in each well of the EZ-TAXIScan and 1.0 μL of either buffer or fMLF (5x10-8 M) or
IL-8 (5x10-8 M) was added to the opposing well. Images of cellular migration were captured
every 30 sec for 60 min at 37°C and individual cells (10 picked at random) were tracked digi-
tally using ImageJ software. The paths of the migrating cells were plotted with the position of
each cell at t = 0 anchored at the origin. Using the coordinates obtained at each time point, the
migratory path of each cell was resolved into a randommigrational vector (orthogonal to the
direction of the chemoattractant, along the x-axis) and a directed migrational vector (parallel
to the direction of the chemoattractant, along the y-axis). In the absence of chemoattractant,
the directed migrational vector should be equivalent to the random migrational vector. For
studies analyzing chemotaxis to several chemoattractants simultaneously, chemoattractants
(fMLF, LTB4, C5a, and IL-8) were prepared at the indicated concentrations in PBS with 0.1%
human serum albumin and loaded in triplicate to the bottom well of a 96-well ChemoTx dis-
posable chemotaxis plate (Neuro Probe, Inc.). Neutrophils were labeled with calcein-AM
(10 μg/mL) and 7.5 x104 added on top of the wells, separated from the chemoattractants by a
5 μm polycarbonate filter. Plates were incubated for 45 min at 37°C, and the fluid in upper
chamber removed. Cells attached to the underside of the filter were detached by washing in 2
mM EDTA. After removing the filter, fluorescence of each well was determined in a multi-well
fluorescent plate reader (SpectraMAX Gemini EM). The number of migrating cells was deter-
mined using a standard curve made with known quantities of labeled cells. To test whether
CSF from our CARD9-deficient Candida-infected patient or CSF from a healthy uninfected
donor or CSF from our CARD9+/+ Candida-infected patient post-Ommaya reservoir place-
ment or CSF from two patients with non-neutrophilic (lymphocytic) meningitis was chemo-
tactic itself toward WT and/or CARD9-deficient neutrophils, the NeuroProbe protocol was
used, using a 50% dilution of CSF as the chemoattractant.
Expression of CARD9 on Neutrophils and CD14+ Monocytes Using
FACS Analysis
Neutrophils and PBMCs were harvested from healthy donors and the CARD9-deficient patient
as described above. Cells were first stained with Live/Dead fluorescent dye (Invitrogen) for 10
minutes on ice, followed by anti-CD16/32 for 10 min to block Fc receptors, and then by APC-
conjugated anti-human CD14 (clone M5E2; BD Biosciences). Cells were then fixed with 2%
paraformaldehyde (Affymetrix) at room temperature for 10 minutes and subsequently
permeabilized with 1X FACS permeabilizing solution 2 (BD Biosciences) according to the
manufacturer’s instructions. The cells were then incubated for 30 minutes with rabbit
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monoclonal anti-CARD9 (clone EPR6489; Origene) or monoclonal rabbit IgG isotype control
(clone EPR25A; Abcam), washed and then stained with PE-conjugated secondary anti-rabbit
antibody (eBioscience) for 30 minutes. Samples were acquired using a BD LSRFortessa.
Expression of CARD9 on Neutrophils and CD14+ Monocytes Using
Western Blot Analysis
Neutrophils and CD14+ monocytes were harvested from healthy donors and the CARD9-defi-
cient patient as described above. Cells were washed once with ice-cold PBS and lysed in buffer
containing 50 mMHEPES, 50 mMNaCl, 10% glycerol, 0.5% Nonidet P-40, 2 mM EDTA, and
a Protease and Phosphatase Inhibitor Cocktail (cat# 78440; Thermo Scientific). Cell lysates
were centrifuged at 13,200 g for 10 minutes at 4°C, and equal protein amounts from the super-
natant were resuspended in SDS loading buffer with 5% β-mercaptoethanol for Western blot
analysis. Proteins were analyzed by SDS-PAGE and transferred to Immobilon P, polyvinyli-
dene difluoride membrane (Millipore, Billerica). Membranes were blocked in TBS-T contain-
ing 5% nonfat dry milk, and then incubated with polyclonal rabbit anti-human CARD9 (cat#
12892-1-AP; ProteinTech Group, Chicago, IL) and rabbit monoclonal antibody against
GAPDH (cat# 2118; Cell Signaling Technology) in TBS-T containing 5% BSA for 2 hours at
room temperature under continuous agitation. Membranes were then washed 3 times with
TBS-T, and incubated with horseradish peroxidase–conjugated anti-rabbit secondary antibody
(Southern Biotech) in TBS-T containing 5% nonfat dry milk for 1 hour at room temperature.
Membranes were subsequently washed, and detection of immunoreactive bands was per-
formed using the SuperSignal West Fempto Maximum Sensitivity Substrate chemilumines-
cence (ECL) detection kit according to the manufacturer’s instructions (Pierce Biotechnology).
Determination of IL-17A+ CD4+ T Cells
PBMCs from healthy donors and the CARD9-deficient patient were isolated as described
above and cultured in RPMI 1640 with 10% FBS, 2mM L-glutamine, 100 U/mL of penicillin,
and 100 μg/mL of streptomycin (Gibco) at 37°C in a humidified 5% CO2 incubator. Intracellu-
lar staining for IL-17A was performed on PBMCs stimulated for 6 hours with PMA (20 ng/ml;
Sigma) and ionomycin (1 μM; Life Technologies) in the presence of Brefeldin A (10 μg/ml;
Sigma). FITC-labeled anti-CD4 (clone RPA-T4; eBioscience) was added for the final 30 min-
utes of culture before the fix and permeabilization step. Cells were then washed with PBS and
then fixed and made permeable with Foxp3 staining set (eBioscience) according to the manu-
facturer's instructions. Cells were then incubated with PE-labeled anti-IL-17A (clone eBio64-
CAP17; eBioscience) for 1 hour at 4°C, and acquired on a FACSCanto (BD Biosciences).
Mice and Systemic Candidiasis Model
8–12 week old female C57BL/6 (Taconic) and Card9-/- [41] mice were maintained in individu-
ally ventilated cages under specific pathogen-free conditions at the National Institutes of
Health (Bethesda, MD, USA). Cxcl2-GFP reporter animals [38] were bred and housed in the
Memorial Sloan Kettering Cancer Center Comparative Medicine Shared Resources under spe-
cific pathogen-free conditions. Candida albicans strain SC5314 was used for all infections.
Yeast was serially passaged 3 times in YPD (yeast extract, bacto-peptone and dextrose) broth,
grown at 30°C with shaking for 18–24 hours at each passage. Yeast cells were washed in PBS,
counted, and injected intravenously via the lateral tail vein. Each animal received 0.7–1.3 x 105
yeast cells (details for doses used in individual experiments are presented in the figure legends).
At 24 or 72 hours post-infection, animals were euthanized and following analyses performed:
brain fungal burdens; FACS analysis on blood, brain and bone marrow cells; quantification of
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chemokines by Luminex array; histopathology; cell sorting; RNA isolation from brain tissue
followed by qRT-PCR analysis.
Depletion of Neutrophils in Infected Mice by 1A8 Administration
WTmice were given 100 μg of 1A8 or 2A3 (isotype) antibody (Bio X Cell) intravenously at
24 hours prior to infection, and again at the time of infection. Antibody-treated mice were
infected with 1 x 105 CFU of C. albicans SC5314, and analyzed at 24 hours post-infection for
brain fungal burden and FACS analysis (see below).
Generation of Mixed Bone Marrow Chimeras
6–8 week old recipient C57BL/6.SJL (CD45.1+) mice were irradiated with 900 rad and left to
rest for 4 hours. Bone marrow from gender-matched C57BL/6.SJL and Card9-/- (CD45.2+)
donor mice was isolated from the femurs, washed and counted using Trypan blue exclusion,
and resuspended as a 1:1 ratio for transfer. Flow cytometry was used to confirm the ratio of
CD45.1+ to CD45.2+ cells prior to use. 5 x 106 total bone marrow cells were transferred to each
irradiated recipient mouse intravenously via the lateral tail vein approximately 4 hours post-
irradiation. Recipient animals were given trimethoprim/sulfamethoxazole in the drinking
water for the first 4 weeks of reconstitution, and then switched to antibiotic-free water. Mice
were left to reconstitute for a total of 8 weeks post-transfer, and chimera status was assessed by
flow cytometry on a sample of peripheral blood. Chimeras were then infected with 1.3 x 105
CFU of SC5314, and euthanized for analysis at 24 or 72 hours post-infection. Brains and
300 μL peripheral blood were stained for flow cytometry analysis as above. WT and Card9-/-
neutrophils (CD45+ CD11b+ Ly6Ghi) were separated based on expression of congenic CD45.1
and CD45.2 markers and the ratio between them calculated.
Determination of Fungal Burdens from Mouse Brains
At 24 or 72 hours post-infection, animals were euthanized and brains and kidneys were
weighed, homogenized in PBS, and serially diluted before plating onto YPD agar supplemented
with Penicillin/Streptomycin (Invitrogen). Colonies were counted after incubation at 37°C for
24–48 hours.
Flow Cytometry of Mouse Bone Marrow, Blood and Brain
Leukocytes were isolated from brain, kidney, blood and bone marrow using previously
described methods [24, 43], resuspended in PBS and stained with fluorochrome-conjugated
antibodies as described for the human samples. Anti-mouse antibodies used in this study were:
CD45 (30-F11), CD11b (M1/70), CD11c (N418), MHC Class II (M5/114.15.2), CD45.1 (A20),
CD3 (145-2C11), CD19 (eBio1D3), F480 (BM8), all from eBiosciences, and CD45.2 (104),
Ly6G (1A8), Ly6C (AL-21), all from BD Biosciences.
FACS Analysis of Neutrophils for Annexin V and 7-AAD Expression
Brain-isolated leukocytes were Fc-blocked and stained with fluorochrome-conjugated antibod-
ies as described above, washed twice with PBS, and resuspended in Annexin V binding buffer
(BD Biosciences). Samples were incubated at room temperature for 15 minutes with 5 μl each
of FITC-conjugated Annexin V and 7-AAD per the manufacturer’s instructions (BD Biosci-
ences). FACS was performed on a 5-laser LSRFortessa.
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Chemokine/Cytokine Quantification in Mouse Brains by Luminex Array
Brains and kidneys were weighed and then homogenized in PBS/0.05% Tween20 and a prote-
ase inhibitor cocktail (Roche). Cell debris was removed by two sequential centrifugation steps
(3600 rpm for 5 minutes, 13200 rpm for 10 minutes), and the resulting supernatant filtered
through 0.2 μm filters, snap-frozen on dry ice and stored at -80°C until analysis. Samples were
analyzed by Luminex assay, as described above, and cytokine/chemokine concentrations were
determined per gram of tissue.
Histopathology
Brains were removed from infected mice at the indicated time points and fixed in 10% formalin
for 24 hours before embedding in paraffin wax. Tissue sections were stained with periodic
acid-Schiff (PAS) and hematoxylin and eosin (H&E).
FACS Sorting of Brain Myeloid and Non-myeloid Cells
WT animals were infected with 1.3 x 105 CFU SC5314 and euthanized at 24 hours post-infec-
tion. Brains were isolated and leukocytes stained as above with sterile antibodies. Neutrophils
(CD45hi CD11b+ Ly6Ghi Ly6Cint), Ly6Chi monocytes (CD45hi CD11b+ Ly6Chi Ly6G-), micro-
glia (CD45lo CD11b+ Ly6G- Ly6C-) and stromal cells (CD45-) were FACS-sorted into sterile
sorting buffer (HBSS supplemented with 2 mM EDTA, 10% FCS, 100 U/mL penicillin, 100 μg/
mL streptomycin) using a FACS Aria instrument. Purity of cells, on average, were as follows:
neutrophils, 90%; monocytes, 88%; microglia, 95%; stromal cells,>99% (S12 Fig). Cells were
then centrifuged (1500 rpm 5 minutes, 4°C) and resuspended in Trizol for RNA purification.
3–5 animals were pooled for individual sorts, and 3–6 independent sorts were performed in
total.
Analysis of Cxcl2 Expression by Brain Myeloid Cells Using Cxcl2-GFP
Reporter Mice
Cxcl2-GFP reporter and non-transgenic WT littermates were infected as described above with
1.3 x 105 CFU SC5314 intravenously and analyzed at 24 hours post-infection. Brains from
infected mice were processed as previously described [24], and stained for FACS analysis as
described above. Cxcl2-GFP expression was determined in the major myeloid populations
(neutrophils, Ly6Chi monocytes and microglia) by comparison with WT (GFP-) cells gated in
the same way.
Generation of cDNA and qRT-PCR
RNA was extracted from either sorted brain myeloid cells or homogenized brain tissue using
Trizol (Invitrogen) and the RNeasy kit (Qiagen) per the manufacturer’s protocol. Purified
RNA was used as a template for cDNA generation using the qScript cDNA SuperMix kit
(Quanta Biosciences) with oligodT and random primers. Quantitative PCR was performed by
SYBR Green (PerfeCTa SYBR Green FastMix ROX; Quanta BioSciences) or TaqMan detection
(PerfeCTa qPCR FastMix ROX; Quanta BioSciences) with the 7900HT Fast Real-Time PCR
System (Applied Biosystems). All qPCR assays were performed in duplicate and the relative
gene expression of each gene was determined after normalization with GAPDH transcript lev-
els using the ΔΔCT method. TaqMan primers/probes (Sell, Selp, Icam1, Itgax, Itgb2, Itgal, Gfap,
Mog, Card9, Il17a, Il22, Gapdh) were predesigned by Applied Biosystems. Primers for SYBR
Green detection were as follows: Gapdh: FOR 5’-aactttggcattgtggaagg, REV 5’-acacattgggggtag
gaaca; Cxcl1: FOR 5’-actgggattcacctcaagaa, REV 5’-tctccgttacttggggacac; Cxcl2: FOR 5’-aagttt
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gccttgaccctgaa, REV 5’-aggcacatcaggtacgatcc; Cxcl5: FOR 5’-gaaagctaagcggaatgcac, REV 5’-
gggacaatggtttccctttt.
Staphylococcus aureus Infection Model
Community-acquired methicillin resistant Staphylococcus aureus USA300 (CA-MRSA, LAC
strain from F. DeLeo, Rocky Mountain Laboratories, NIAID) was grown in brain heart infu-
sion broth (BHI, Difco Laboratories, Detroit, Mich.) at 37°C with shaking at 230 rpm for 18
hours. The culture was then centrifuged at 3000 rpm for 10 minutes at room temperature and
the pellet washed twice with PBS. WT and Card9-/- mice were infected intravenously with 2 x
107 CFU via the lateral tail vein, and animals euthanized at 48 hours post-infection and ana-
lyzed as described above.
Statistics
Statistical analyses were performed using GraphPad Prism 6.0 software. Details of individual
tests are included in the figure legends. In general, data was tested for normal distribution by
Kolmogorov-Smirnov normality test and analyzed accordingly by unpaired two-tailed t-test or
MannWhitney U-test. In cases where multiple data sets were analyzed, two-way ANOVA was
used with Bonferroni correction. In all cases, P values<0.05 were considered significant.
Supporting Information
S1 Fig. Schematic diagram of the human CARD9 gene domains and the CARD9mutations
that have been reported to result in fungal disease. The CARD and coiled-coil (CC) domains
are indicated along with reported CARD9mutations. The R57H mutation of our patient is
indicated in red and the previously reported mutations associated with fungal infection of the
CNS are indicated in blue.
(TIFF)
S2 Fig. CARD9 is not expressed by CD4+ T-cells. FACS histogram of CARD9 staining in
CD4+ T-cells from a healthy donor, compared to the isotype control.
(TIFF)
S3 Fig. The c.170G>A CARD9missense mutation results in impaired production of pro-
inflammatory mediators by PBMCs upon fungal stimulation. Cytokine (left panel) and che-
mokine (right panel) production by healthy donor (n = 10) and patient (n = 4) PBMCs after 48
hours of stimulation with heat-killed C. albicans (n = 4–10 independent experiments). Data is
analyzed by MannWhitney U-test or unpaired t-test, where appropriate. P< 0.05;
P< 0.01; P< 0.001; P< 0.0001. Data represent mean ± SEM.
(TIFF)
S4 Fig. CARD9 deficiency results in Candida fungal invasion in the CNS without neutro-
phil tissue infiltration. (A)Hematoxylin and eosin (H&E), (B) Grocott-Gomori methena-
mine-silver (GMS) and (C) Periodic acid-Schiff (PAS) stains of the patient’s brain biopsy
sample showing filamentous fungal elements consistent with C. albicans and absence of neu-
trophil infiltration in the infected tissue (magnification, A, ×100; B-C, ×200).
(TIFF)
S5 Fig. Card9-/- mice have reduced neutrophil frequency in the brain during fungal infec-
tion. (A) Neutrophil frequency was determined by FACS in the brain of WT (filled bars, 0
hours n = 5, 24 hours n = 6–13, 72 hours n = 6–13) and Card9-/- (empty bars, 0 hours n = 5–6,
24 hours n = 6–14, 72 hours n = 6–12) mice; data analyzed by two-way ANOVA. Example
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plots are from 24 hours post-infection and gated on live CD45+ single cells. (B) Relative fre-
quencies of different subsets of hematopoietic CD45+ cells in the brain of WT (n = 6) and
Card9-/- (n = 6) mice at 24 hours post-infection (dose: 1.3x105 CFU) was determined by FACS.
‘Other (myeloid)’ cells represent eosinophils, dendritic cells and macrophages. Data is pooled
from two independent experiments. P<0.01, P<0.005 by two-way ANOVA. Data repre-
sent mean ± SEM.
(TIFF)
S6 Fig. Card9-/- mice mobilize neutrophils into the C. albicans infected kidney. (A) Kidney
fungal burdens in WT (filled circles) and Card9-/- (empty circles) mice at 24 (WT n = 12, KO
n = 11) and 72 (WT n = 12, KO n = 10) hours post-infection; data pooled from 3–4 indepen-
dent experiments and analyzed by MannWhitney U-test. (B) Neutrophil numbers were deter-
mined by FACS in the left kidney of WT (filled bars, n = 6 per time point) and Card9-/- (empty
bars, n = 6 per time point) mice; data analyzed by two-way ANOVA. (C) Whole kidney
homogenates were analyzed for Cxcl1, Cxcl2 and Cxcl5 in uninfected and infected WT (filled
bars, n = 6 per time point) and Card9-/- (empty bars, n = 6 per time point) mice by Luminex
array. Data is pooled from two independent experiments and analyzed by two-way ANOVA.
P<0.05, P<0.01, P<0.005, P<0.001. Data represent mean ± SEM.
(TIFF)
S7 Fig. Card9 is dispensable for control of bacterial growth and neutrophil accumulation
in the brain following S. aureus infection.WT (n = 7) and Card9-/- (n = 9) mice were infected
intravenously with 2x107 CFU of S. aureus and euthanized at 48 hours post-infection for (A)
bacterial brain burden and (B) accumulation of neutrophils in the brain by FACS. Data is
pooled from two independent experiments.
(TIFF)
S8 Fig. WT and Card9-/- mice produce comparable numbers of neutrophils in the bone
marrow, during steady state and post-infection. (A) The number of early neutrophil progeni-
tors (Ly6Gint CD11b+) and (B) total neutrophils (Ly6Gint CD11b+ and Ly6Ghi CD11b+ com-
bined) were determined by FACS in the bone marrow of WT (filled bars, 0 hours n = 6, 24
hours n = 6, 72 hours n = 7) and Card9-/- (empty bars, 0 hours n = 7, 24 hours n = 6, 72 hours
n = 6) mice at indicated time points. Mice analyzed at 24 hours were infected with 1.3x105
CFU SC5314, and mice analyzed at 72 hours infected with 7x104 CFU. Data is pooled from 2–4
independent experiments and analyzed by two-way ANOVA. P<0.05, P<0.01. Data repre-
sent mean ± SEM.
(TIFF)
S9 Fig. Schematic of mixed bone marrow chimera generation.WT CD45.1+ and Card9-/-
CD45.2+ animals were used as donors for the isolation of bone marrow cells that were mixed in
a 1:1 ratio prior to transfer. Mixed bone marrow was injected intravenously into irradiated WT
CD45.1+ recipient mice, which were left to reconstitute for 8 weeks post-transfer. Chimera sta-
tus was confirmed by FACS on a sample of peripheral blood prior to infection.
(TIFF)
S10 Fig. Induction of neutrophil-targeted adhesion molecules in the C. albicans infected
WTmouse brain.WT animals were systemically infected with a low (7x104) or a high inocu-
lum (1x106) of C. albicans SC5314 and brains assessed for expression of indicated adhesion
molecules by qRT-PCR. Data is analyzed by two-way ANOVA. P<0.01, P<0.001. Data
represent mean ± SEM.
(TIFF)
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S11 Fig. Chemokine production in the brain of uninfected and infected WT and Card9-/-
mice.Whole brain homogenates were analyzed for Cxcl1, Cxcl2 and Cxcl5 in uninfected and
infected WT (filled bars) and Card9-/- (empty bars) mice by Luminex array. Mice analyzed at
24 hours were infected with 1.3x105 CFU SC5314, and mice analyzed at 72 hours infected with
7x104 CFU. Data is pooled from two independent experiments and analyzed by two-way
ANOVA. P<0.05, P<0.01, P<0.005, P<0.001. n = 6 per time point. Data represent
mean ± SEM.
(TIFF)
S12 Fig. Purities of cells FACS-sorted from the mouse brain. (A) Representative post-sort
analysis of neutrophils, microglia and CD45- stromal cells. Left-hand plots are ungated, right-
hand plots are gated on CD45+ cells. (B) Frequency of indicated sorted populations from two
independent sorts (WT n = 6, KO n = 6). No post-sort analysis was performed on Ly6Chi
monocytes due to insufficient numbers acquired. (C) Quantification of Gfap andMog tran-
scripts in the CD45- sorted population (WT n = 6, KO n = 6). (D) Example CD102/CD31
staining on sorted CD45- cells, gated on CD45- singlets. Plot is representative of 6 sorted popu-
lations, from two independent experiments.
(TIFF)
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